Encompass Health Corp
EHC
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.24B
Close$
$88.47
28.7% downside
Current Fair Value
28.7% downsideOvervalued by 28.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.24 Billion |
|---|---|
| Enterprise Value | $14.98 Billion |
| Dividend Yield | $0.78 (0.63%) |
| Earnings per Share | $5.62 |
| Beta | 0.6 |
| Outstanding Shares | 98,800,000 |
Return
| Return on Equity | 23.91% |
|---|---|
| Return on Assets | 8.33% |
| Return on Invested Capital | 14.00% |
Valuation & Multiples
| P/E Ratio | 19.95 |
|---|---|
| PEG | 240.25 |
| Price to Sales | 2.0 |
| Price to Book Ratio | 3.55 |
| Enterprise Value to Revenue | 2.41 |
| Enterprise Value to EBIT | 16.25 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 1.09 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$1.48
Average shareholder expectationRevenue Estimate
$1.57 B
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$1.36
Average shareholder expectationRevenue Estimate
$1.60 B
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 105.50% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 3.22%▼ 94.35% |
|---|---|
| Total Invested | $386.81M▼ 96.01% |
| Investors Holding | 117▼ 496.00% |
ESG Score
No data
About Encompass Health Corp
CEO: Mark Tarr